Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00652899 · OUTCOME

Median Overall Survival Number of Days Patients Alive After Treatment

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Days
Interval / dispersion
95% Confidence Interval
Time frame
From first date on-study (treatment) to date of death

What was measured

Median number of days patients alive from date of treatment to date of death or date of last follow-up if censored.

Groups in this outcome

Total Body Irradiation

This group includes patients that received chemotherapy, infusion of natural killer cells and total body irradiation per protocol.

No Total Body Irradiation

This group includes patients that received chemotherapy, infusion of natural killer cells and no total body irradiation per protocol.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Total Body Irradiation5
No Total Body Irradiation7

Reported measurements

Source class 1
Values in Days · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Total Body Irradiation171.5Not reported144199Not reported
No Total Body Irradiation291Not reported8301Not reported
Complete source fields
anticipated Posting Date
2010-05
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        144
        upper Limit
        199
        value
        171.5
      2. group Id
        OG001
        lower Limit
        8
        upper Limit
        301
        value
        291
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    2. group Id
      OG001
      value
      7
    units
    Participants
description
Median number of days patients alive from date of treatment to date of death or date of last follow-up if censored.
dispersion Type
95% Confidence Interval
groups
  1. description
    This group includes patients that received chemotherapy, infusion of natural killer cells and total body irradiation per protocol.
    id
    OG000
    title
    Total Body Irradiation
  2. description
    This group includes patients that received chemotherapy, infusion of natural killer cells and no total body irradiation per protocol.
    id
    OG001
    title
    No Total Body Irradiation
param Type
MEDIAN
reporting Status
POSTED
time Frame
From first date on-study (treatment) to date of death
title
Median Overall Survival Number of Days Patients Alive After Treatment
type
SECONDARY
unit Of Measure
Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice